36.59
-0.05 (-0.14%)
| Previous Close | 36.64 |
| Open | 36.62 |
| Volume | 2,084,739 |
| Avg. Volume (3M) | 2,094,474 |
| Market Cap | 7,546,687,488 |
| Price / Earnings (TTM) | 18.67 |
| Price / Earnings (Forward) | 11.53 |
| Price / Sales | 3.58 |
| Price / Book | 2.27 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2026 |
| TTM Dividend Yield | 0.64% |
| Profit Margin | 4.68% |
| Operating Margin (TTM) | 25.89% |
| Diluted EPS (TTM) | 0.430 |
| Quarterly Revenue Growth (YOY) | 5.40% |
| Quarterly Earnings Growth (YOY) | 12.50% |
| Total Debt/Equity (MRQ) | 41.36% |
| Current Ratio (MRQ) | 3.37 |
| Operating Cash Flow (TTM) | 680.21 M |
| Levered Free Cash Flow (TTM) | 622.84 M |
| Return on Assets (TTM) | 5.75% |
| Return on Equity (TTM) | 2.67% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Qiagen N.V. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.50 |
|
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%). |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Core |
| % Held by Insiders | 1.61% |
| % Held by Institutions | 86.26% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |